We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News   Oct 19, 2017 | Original Story from Oak Ridge National Laboratory

 
Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

An ORNL-led team used neutrons to observe the AAT enzyme, a vitamin B6-dependent protein, and found that the chemical reaction occurred only in one active site. Nuclear scattering length density maps (colored mesh) highlight the positions of critical hydrogen atoms, including a low-barrier hydrogen bond (magenta mesh) not thought to exist in AAT, which may be crucial for catalysis. Credit: Jill Hemman and Andrey Kovalevsky /Oak Ridge National Laboratory, US Dept. of Energy.

 
 
 

RELATED ARTICLES

Toxin in Bacteria Hijacks and Modifies Human Proteins

News

A team of scientists discovered that the toxin SidJ in Legionella bacteria enforces a unique modification on human proteins and helps legionella grow inside human cells.

READ MORE

Immune Cells Put Into Gear by Molecular "Clutch"

News

Proteins that drive activation of our immune response, by acting as a ‘clutch’ to move clusters of proteins within cells, have been identified. This could open opportunities to design immune cells to combat specific problems.

READ MORE

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE